111 related articles for article (PubMed ID: 24877604)
21. Care management and contemporary challenges in spina bifida: a practice preference survey of the American Society of Pediatric Neurosurgeons.
Alford EN; Hopson BD; Safyanov F; Arynchyna A; Bollo RJ; Hankinson TC; Rocque BG; Blount JP
J Neurosurg Pediatr; 2019 Aug; 24(5):539-548. PubMed ID: 31470398
[TBL] [Abstract][Full Text] [Related]
22. Do P-glycoprotein Medications Alter the Risk of Ventriculoperitoneal Shunt in Adults with Hydrocephalus?
Grullon JR; Koutsouras GW; Onwumere NF; Lehmann DF; Krishnamurthy S
J Clin Pharmacol; 2024 Mar; 64(3):371-377. PubMed ID: 37751442
[TBL] [Abstract][Full Text] [Related]
23. Differences between Myeloschisis and Myelomeningocele in patients undergoing prenatal repair of Open Spina Bifida.
Müller JM; Corral Sereño E; Jimenez A; Zapata R; Echeverria S; Jara JP; Santibanez A; Lindsay C; Anfossi R
Fetal Diagn Ther; 2024 Mar; ():. PubMed ID: 38471477
[TBL] [Abstract][Full Text] [Related]
24. Does the timing of surgery affect short-term prognosis in newborn infants with meningomyelocele?
Mert MK; Ökten Aİ
Neuro Endocrinol Lett; 2023 Oct; 44(7):475-481. PubMed ID: 37874554
[TBL] [Abstract][Full Text] [Related]
25. Congenital myelomeningocele - do we have to change our management?
Mayer S; Weisser M; Till H; Gräfe G; Geyer C
Cerebrospinal Fluid Res; 2010 Oct; 7():17. PubMed ID: 20946644
[TBL] [Abstract][Full Text] [Related]
26. Myelomeningocele repair at pediatric hospitals: association with routine discharge and shorter hospital stay.
Han JS; Rangwala SD; Ge BB; Liu KQ; Ding L; Mack WJ; Durham S; Krieger MD; Attenello FJ
J Neurosurg Pediatr; 2023 Sep; 32(3):376-383. PubMed ID: 37347655
[TBL] [Abstract][Full Text] [Related]
27. Intracranial volumetric evaluation in postnatally repaired myelomeningocele infants.
Hashimoto H; Irizato N; Takemoto O; Chiba Y
Childs Nerv Syst; 2024 May; ():. PubMed ID: 38714605
[TBL] [Abstract][Full Text] [Related]
28. Global Surgery Indicators and Pediatric Hydrocephalus: A Multicenter Cross-Country Comparative Study Building the Case for Health System Strengthening.
Ferraris KP; Palabyab EPM; Kim S; Matsumura H; Yap MEC; Cloma-Rosales VO; Letyagin G; Muroi A; Baticulon RE; Alcazaren JC; Seng K; Navarro JE
Front Surg; 2021; 8():704346. PubMed ID: 34513913
[No Abstract] [Full Text] [Related]
29. Outcomes of hydrocephalus secondary to congenital toxoplasmosis.
McLone D; Frim D; Penn R; Swisher CN; Heydemann P; Boyer KM; Noble AG; Rabiah PK; Withers S; Wroblewski K; Karrison T; Hutson S; Wheeler K; Cohen W; Lykins J; McLeod R
J Neurosurg Pediatr; 2019 Sep; 24(5):601-608. PubMed ID: 31491752
[TBL] [Abstract][Full Text] [Related]
30. Postnatal myelomeningocele closure in smallest reported neonate: illustrative case.
Mohis MM; Cordeiro K; Larson S; Garland C; Stadler JA
J Neurosurg Case Lessons; 2024 Mar; 7(10):. PubMed ID: 38437685
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid disturbances after transcallosal surgery: incidence and predictive factors.
Dorfer C; Hosmann A; Vendl J; Steiner I; Slavc I; Gojo J; Kasprian G; Czech T
J Neurosurg; 2019 Sep; 133(4):979-987. PubMed ID: 31561218
[TBL] [Abstract][Full Text] [Related]
32. Persistent Hydrocephalus, Shunt, and Subglottic Stenosis in a Newborn with Plasminogen Deficiency due to Delayed Treatment with Plasminogen Concentrates: A Case Report.
Biesinger BS; Male C; Kranebitter V; Binder J; Niederle MB; Reinprecht A; Binder C
Neonatology; 2024; 121(2):266-270. PubMed ID: 38043518
[TBL] [Abstract][Full Text] [Related]
33. In utero Repair of Myelomeningocele: Rationale, Initial Clinical Experience and a Randomized Controlled Prospective Clinical Trial.
Danzer E; Flake AW
Neuroembryology Aging; 2008 Mar; 4(4):165-174. PubMed ID: 22479081
[TBL] [Abstract][Full Text] [Related]
34. Socioeconomic characteristics and postoperative outcomes of patients undergoing prenatal vs. postnatal repair of myelomeningoceles.
Kalluri AL; Jiang K; Abu-Bonsrah N; Ammar A; Reynolds R; Alomari S; Odonkor MN; Bhimreddy M; Ram N; Robinson S; Akbari SHA; Groves ML
Childs Nerv Syst; 2024 Apr; 40(4):1177-1184. PubMed ID: 38133684
[TBL] [Abstract][Full Text] [Related]
35. Prognostic risk factors for early outcomes of patients with myelomeningocele: a prospective study.
Naseri Alavi SA; Rezkhah A; Majdi A; Habibi MA; Bagheri MM; Jafarzadeh F; Kobets AJ
Childs Nerv Syst; 2024 Jun; ():. PubMed ID: 38847879
[TBL] [Abstract][Full Text] [Related]
36. Ventricular size measurement methods in fetuses considered for prenatal closure of myelomeningocele.
Lundy P; Vlastos E; Domino J; Mitchell GS; Fickenscher K; Grabb P
J Neurosurg Pediatr; 2021 May; 28(2):147-151. PubMed ID: 34049276
[TBL] [Abstract][Full Text] [Related]
37. Ventriculoperitoneal shunt entry points in patients undergoing shunt placement: A single-center study.
Baregzai Y; Al-Salihi MM; Al Hajali A; Hammadi F; Ayyad A
World Neurosurg X; 2024 Jul; 23():100337. PubMed ID: 38497063
[TBL] [Abstract][Full Text] [Related]
38. Artificial neural networks predict the need for permanent cerebrospinal fluid diversion following posterior fossa tumor resection.
Bray DP; Saad H; Douglas JM; Grogan D; Dawoud RA; Chow J; Deibert C; Pradilla G; Nduom EK; Olson JJ; Alawieh AM; Hoang KB
Neurooncol Adv; 2022; 4(1):vdac145. PubMed ID: 36299798
[TBL] [Abstract][Full Text] [Related]
39. Using 'Catheter à Fentes' for Management of Childhood Hydrocephalus: A Prospective Study of Ninety-six Cases.
Sanoussi S; Bawa M; Kelani A; Sani RM; Bazira L
J Surg Tech Case Rep; 2010 Jan; 2(1):13-6. PubMed ID: 22091323
[TBL] [Abstract][Full Text] [Related]
40. 2- to 20-year myelomeningocele follow-up outcomes from a referral center in Southern Iran: the Shiraz experience.
Zoghi S; Mosayebi MA; Feili M; Eskandari H; Jalalinezhad H; Masoudi MS; Taheri R
Eur J Med Res; 2024 Mar; 29(1):200. PubMed ID: 38528560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
